Colon Cancer Screening: How to Prevent Colon Cancer
In the early stages of colon cancer — on the fourth most common cancer in the US and the second leading cause of cancer death – usually has no obvious…
FDA lifts partial clinical hold on Curis cancer drug in lymphoma study – MedCity News
Cancer drug developer Curis now has the FDA’s blessing to resume one of two clinical trials that were halted in the spring after a patient died. Curis said Thursday that…
Sanofi drops out of breast cancer drug race after another failed attempt – MedCity News
Sanofi is officially out of the race to develop a breast cancer drug in pill form that could compete with a blockbuster injection therapy. The pharmaceutical giant’s challenger, amcenestrant, has…
Gilead claims it has won the breast cancer trial, but offers few details; drug application is filed with the FDA – MedCity News
Gilead Sciences now has more clinical data showing that breast cancer drug Trodelvy has helped patients live longer. The FDA already has that data, too, as the drugmaker said Monday…
Shares of Gilead rose about 4% after sharing new data on a cancer drug
Shares of Gilead Sciences Inc. GILD, +5.06% rose 4.9% in Monday trading after the company said in a news release that Trodelvy improved overall survival rates in people with HR+/HER2-…
Cancer cells are most active during sleep, study finds
In 2017, actor and singer Olivia Newton-John announced that she had breast cancer for the third time. Two years later, she began suffering from back pain and had to cancel…
AstraZeneca & Daiichi drug wins another FDA approval, this time for lung cancer – MedCity News
AstraZeneca and Daiichi Sankyo’s Enhertu drug is on a hot streak, winning FDA approval for lung cancer, marking the second positive regulatory decision in a week. The The FDA approval…
FDA approval for AstraZeneca drug is first for new group of breast cancer patients – MedCity News
A breast cancer drug from AstraZeneca and Daiichi Sankyo is now available FDA approval to address a brand new category of disease, a solution that allows targeted therapy to reach…
AmeriHealth New Jersey partners with Thyme Care to help members on their cancer journey – MedCity News
Health insurer AmeriHealth New Jersey has partnered with Thyme Care, an oncology care management company, to help its members cope with cancer diagnoses. The new union starts on 1 January…
Ipsen’s latest R&D alliance brings new T-cell-activated cancer drugs – MedCity News
Amidst reaching an acquisition deal that brings Ipsen a commercialized drug for follicular lymphoma, the Paris-based drugmaker is expanding its reach in cancer through license deal which took him into…